Skip to content

flunarizine therapy in reducing vertigo symptoms among patients with vestibular migraine.

Prophylactic flunarizine therapy in reducing vestibular symptoms among vestibular migraine patients. An interventional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021185
Enrollment
50
Registered
2019-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H818- Other disorders of vestibular function

Interventions

Intervention1: Flunarizine: Flunarizine 10mg once daily dosage for a period of 2months Control Intervention1: Not applicable: Not applicable

Sponsors

Farnaz Nasrin ISlam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed as migraine as per ICH 3beta criteria above 18 years for the initial screening Patients with vestibular migraine will be screened as per ICH 3beta criteria Patients with vestibular migraine will be included for VEMP and further follow-up

Exclusion criteria

Exclusion criteria: Patients accounting for other causes of headache Patients with other vestibular dysfunctions Patients with hearing loss

Design outcomes

Primary

MeasureTime frame
Patients diagnosed as vestibular migraine as per ICH 3beta criteria will be assessed clinically and initial VEMP TEST will be carried out. Patient will be started with Flunarizine. Patients will be followed up VEMP will be repeated at 2 monthsTimepoint: Initial VEMP test will be done followed by VEMP after 2 months of Flunarizine therapy to assess any objective and subjective improvement

Secondary

MeasureTime frame
Clinical improvement in vestibular symptoms after Flunarizine therapyTimepoint: Initial assessment and monthly follow-up for 2 months;Specific changes in VEMPsTimepoint: Initial VEMP and VEMP after 2months of Flunarizine therapy

Countries

India

Contacts

Public ContactFarnaz Nasrin Islam

Manipal Academy of Higher Education

dr.deviprasad@yahoo.co.in9900135975

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026